Annual Total Long Term Liabilities
$46.68 M
-$1.38 M-2.86%
December 31, 2022
Summary
- As of February 11, 2025, MRTX annual total long term liabilities is $46.68 million, with the most recent change of -$1.38 million (-2.86%) on December 31, 2022.
- During the last 3 years, MRTX annual total long term liabilities has risen by +$45.68 million (+4572.97%).
Performance
MRTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$45.86 M
-$238.00 K-0.52%
September 30, 2023
Summary
- As of February 11, 2025, MRTX quarterly total long term liabilities is $45.86 million, with the most recent change of -$238.00 thousand (-0.52%) on September 30, 2023.
- Over the past year, MRTX quarterly long term liabilities has dropped by -$1.18 million (-2.51%).
Performance
MRTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MRTX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.9% | -2.5% |
| 3 y3 years | +4573.0% | +2876.3% |
| 5 y5 years | +10000.0% | +6817.6% |
MRTX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.9% | at low | -5.7% | at low |
| 5 y | 5-year | -2.9% | -97.9% | -5.7% | -97.8% |
| alltime | all time | -2.9% | -100.0% | -5.7% | -100.0% |
Mirati Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $45.86 M(-0.5%) |
| Jun 2023 | - | $46.10 M(-0.9%) |
| Mar 2023 | - | $46.53 M(-0.3%) |
| Dec 2022 | $46.68 M(-2.9%) | $46.68 M(-0.8%) |
| Sep 2022 | - | $47.04 M(-3.3%) |
| Jun 2022 | - | $48.64 M(+0.4%) |
| Mar 2022 | - | $48.45 M(+0.8%) |
| Dec 2021 | $48.06 M(+9.6%) | $48.06 M(+1.5%) |
| Sep 2021 | - | $47.33 M(+3.1%) |
| Jun 2021 | - | $45.91 M(+3.6%) |
| Mar 2021 | - | $44.31 M(+1.0%) |
| Dec 2020 | $43.87 M(+4291.1%) | $43.87 M(+2746.7%) |
| Sep 2020 | - | $1.54 M(+23.2%) |
| Jun 2020 | - | $1.25 M(+6.6%) |
| Mar 2020 | - | $1.17 M(+17.5%) |
| Dec 2019 | $999.00 K(+36.5%) | $999.00 K(+14.4%) |
| Sep 2019 | - | $873.00 K(+14.7%) |
| Jun 2019 | - | $761.00 K(+8.1%) |
| Mar 2019 | - | $704.00 K(-3.8%) |
| Dec 2018 | $732.00 K(+133.1%) | $732.00 K(+10.4%) |
| Sep 2018 | - | $663.00 K(-7.1%) |
| Jun 2018 | - | $714.00 K(+3.0%) |
| Mar 2018 | - | $693.00 K(+120.7%) |
| Dec 2017 | $314.00 K(+136.1%) | $314.00 K(-4.6%) |
| Sep 2017 | - | $329.00 K(+17.5%) |
| Jun 2017 | - | $280.00 K(-23.7%) |
| Mar 2017 | - | $367.00 K(+175.9%) |
| Dec 2016 | $133.00 K(+209.3%) | $133.00 K(+923.1%) |
| Sep 2016 | - | $13.00 K(-45.8%) |
| Jun 2016 | - | $24.00 K(-29.4%) |
| Mar 2016 | - | $34.00 K(-20.9%) |
| Dec 2015 | $43.00 K(+104.8%) | $43.00 K(-17.3%) |
| Sep 2015 | - | $52.00 K(-10.3%) |
| Jun 2015 | - | $58.00 K(+190.0%) |
| Mar 2015 | - | $20.00 K(-4.8%) |
| Dec 2014 | $21.00 K | $21.00 K(>+9900.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(-100.0%) |
| Jun 2013 | - | $11.00 K(-59.3%) |
| Mar 2013 | - | $27.00 K(-40.0%) |
| Dec 2012 | $45.00 K(+64.2%) | $45.00 K(+7.9%) |
| Sep 2012 | - | $41.70 K(+17.8%) |
| Jun 2012 | - | $35.40 K(+10.3%) |
| Mar 2012 | - | $32.10 K(+17.2%) |
| Dec 2011 | $27.40 K(-98.5%) | $27.40 K(-86.3%) |
| Sep 2011 | - | $199.50 K(-27.6%) |
| Jun 2011 | - | $275.70 K(-19.5%) |
| Mar 2011 | - | $342.60 K(-80.7%) |
| Dec 2010 | $1.77 M(-36.3%) | $1.77 M(-21.5%) |
| Sep 2010 | - | $2.26 M(-5.7%) |
| Jun 2010 | - | $2.39 M(-10.2%) |
| Mar 2010 | - | $2.66 M(-4.1%) |
| Dec 2009 | $2.78 M(+3.8%) | $2.78 M(+9.7%) |
| Sep 2009 | - | $2.53 M(+1.7%) |
| Jun 2009 | - | $2.49 M(+2.3%) |
| Mar 2009 | - | $2.43 M(-9.1%) |
| Dec 2008 | $2.68 M(-82.4%) | $2.68 M(-16.5%) |
| Sep 2008 | - | $3.21 M(-77.8%) |
| Jun 2008 | - | $14.43 M(-6.1%) |
| Mar 2008 | - | $15.37 M(+0.9%) |
| Dec 2007 | $15.23 M(-6.8%) | $15.23 M(-5.2%) |
| Sep 2007 | - | $16.07 M(+0.6%) |
| Jun 2007 | - | $15.98 M(+2.1%) |
| Mar 2007 | - | $15.65 M(-4.3%) |
| Dec 2006 | $16.35 M(+691.2%) | $16.35 M(-9.3%) |
| Sep 2006 | - | $18.03 M(-5.3%) |
| Jun 2006 | - | $19.03 M(+0.9%) |
| Mar 2006 | - | $18.86 M(+812.6%) |
| Dec 2005 | $2.07 M(+14.5%) | $2.07 M(-5.5%) |
| Sep 2005 | - | $2.19 M(-1.0%) |
| Jun 2005 | - | $2.21 M(+4.7%) |
| Mar 2005 | - | $2.11 M |
| Dec 2004 | $1.81 M(-43.0%) | - |
| Dec 2003 | $3.17 M | - |
FAQ
- What is Mirati Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Mirati Therapeutics?
- What is Mirati Therapeutics annual total long term liabilities year-on-year change?
- What is Mirati Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly long term liabilities year-on-year change?
What is Mirati Therapeutics annual total long term liabilities?
The current annual total long term liabilities of MRTX is $46.68 M
What is the all time high annual total long term liabilities for Mirati Therapeutics?
Mirati Therapeutics all-time high annual total long term liabilities is $48.06 M
What is Mirati Therapeutics annual total long term liabilities year-on-year change?
Over the past year, MRTX annual total long term liabilities has changed by -$1.38 M (-2.86%)
What is Mirati Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of MRTX is $45.86 M
What is the all time high quarterly long term liabilities for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly total long term liabilities is $48.64 M
What is Mirati Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, MRTX quarterly total long term liabilities has changed by -$1.18 M (-2.51%)